Lymphatic transport of halofantrine in the conscious rat when administered as either the free base or the hydrochloride salt: effect of lipid class and lipid vehicle dispersion.
The intestinal lymphatic transport of halofantrine, an important, highly lipophilic antimalarial drug, has been studied in a conscious rat model after oral administration. In these studies, the lymphatic transport of Hf free base when coadministered with lipid was approximately 20% of the administered dose compared with 5% transport after administration of the HCl salt with or without lipid. These differences in transport can be attributed to the increased lipophilicity of the free base (relative to the HCl salt) thereby facilitating greater association of Hf base with the products of luminal lipid digestion and the subsequent interaction with the intestinally derived chylomicrons responsible for lymphatic drug transport. In contrast to previous results in an anesthetized rat model where lymphatic transport was dependent on the characteristics of the intraduodenally administered lipid formulations, the lymphatic transport of Hf base in the conscious rat was independent of both the class of administered lipid (triglyceride or fatty acid) and the extent of formulation dispersion (micellar lipid or lipid solution). Considering the different lymphatic transport profiles of Hf base in the anesthetized and conscious rat models, it is proposed that the lipid vehicle effects observed in the intraduodenally dosed anesthetized model most likely reflects the lack of gastric processing by preduodenal lipase and the shear action of the stomach otherwise present in the conscious rat model.
Department of Pharmaceutics, Monash University, Parkville, Victoria, Australia.
C J
CJ
Porter
S A
SA
Charman
A J
AJ
Humberstone
W N
WN
Charman
D000284:Administration, Oral; D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage*; D004337:Drug Carriers; D005227:Fatty Acids / Q000378:metabolism; D007408:Intestinal Absorption; D008074:Lipoproteins / Q000378:metabolism; D008208:Lymphatic System / Q000378:metabolism*; D008297:Male; D008823:Micelles; D010616:Phenanthrenes / Q000008:administration & dosage* / Q000378:metabolism; D011485:Protein Binding; D051381:Rats; D017207:Rats, Sprague-Dawley; D014280:Triglycerides / Q000378:metabolism
D000962:Antimalarials; D004337:Drug Carriers; D005227:Fatty Acids; D008074:Lipoproteins; D008823:Micelles; D010616:Phenanthrenes; D014280:Triglycerides; C023768:halofantrine